A pilot study on the safety and efficacy of Abelmoschus Esculentus (Okra) 5% extract in the treatment of non-bullous impetigo among paediatric patients at Jose R. Reyes Memorial Medical Center, Department of Dermatology.
- Author:
Andrea Marie Bernales-Mendoza
1
;
Daisy King-Ismael
2
Author Information
- Publication Type:Journal Article
- From: Journal of the Philippine Medical Association 2021;100(1):80-86
- CountryPhilippines
- Language:English
- Abstract: INTRODUCTION:Impetigo Is a common, contagious, superficial skin infection most commonly presenting as erythematous crusting papules and pustules on the face and or extremities. The pathogens usually implicated in this skin disease are gram- positive organisms including Staphylococcus aureus, and less frequently, group A β-hemolytic Streptococcus pyogenes. In JRRMMC, Department of Dermatology, this disease always ranks in the top 1 O most common skin diseases annually. Treatment options for this disease include topical and oral antibiotics depending on the condition's severity. Mupirocin and Fusidic acid are considered as gold standard in the treatment of impetigo.
- Full text:pilot.pdf
